Chemistry: analytical and immunological testing – Involving an insoluble carrier for immobilizing immunochemicals – Carrier is a biological cell or cell fragment
Reexamination Certificate
2007-07-24
2007-07-24
Schnizer, Richard (Department: 1635)
Chemistry: analytical and immunological testing
Involving an insoluble carrier for immobilizing immunochemicals
Carrier is a biological cell or cell fragment
C424S001170
Reexamination Certificate
active
10311261
ABSTRACT:
According to the present invention, there is provided a delivery vehicle including sickle red blood cells carrying a moiety. The moiety can be any type of diagnostic or therapeutic agent. The present invention further provides for a method of diagnosing systemic hypoxia, acidosis, or hypertonicity by administering sickle red blood cells to a patient and detecting the location of the sickle red blood cells. Additionally, the present invention provides for a method of therapeutic treatment of systemic hypoxia, acidosis, or hypertonicity by administering sickle red blood cells to a patient. Further, the present invention provides for a delivery vehicle that specifically localizes or concentrates at systemic hypoxia, acidosis, or hypertonicity areas. The delivery vehicle is used in diagnosing and therapeutically treating these areas of hypoxia, acidosis, or hypertonicity also. The present invention further provides for a method of making the delivery vehicle described herein.
REFERENCES:
patent: 5939456 (1999-08-01), Perrine
patent: 6011000 (2000-01-01), Perrine et al.
patent: 6197278 (2001-03-01), Blankenberg et al.
patent: 6231880 (2001-05-01), Perrine
Fabry et al (Proc. Nat. Acad. Sci. USA 86: 3308-3812, 1989).
Verma et al (Nature 389: 239-242, 1997).
Anderson (Nature 392:25-30, 1998).
Romano et al (Stem Cells 18: 19-39, 2000).
Somia and Verma (Nature Reviews Genetics 1: 91-99, 2000).
Orkin and Motulsky (Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy, p. 1-38, Dec. 7, 1995.
Ehrenreich et al (Cleveland Clinic journal of medicine, (Mar.-Apr. 1995) 62 (2) 105-16).
Tzeng et al (Journal of pharmacokinetics and biopharmaceutics, (Jun. 1992) 20 (3) 227-51)).
Al-Ali (Acta Haem. 108: 19-22, 2002).
Kruise et al (Biotechnology and Applied Biochemistry 9(2):123-140, 1987).
Slavin et al (Brit. J. Surg. 79(9): 918-921, 1992).
Brown Stephen Lawrence
Kim Jae Ho
Swerdlow Paul S.
Henry Ford Health System
Kohn Kenneth I.
Kohn & Associates PLLC
Schnizer Richard
Wayne State University
LandOfFree
Imaging and targeting tumors using sickle cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imaging and targeting tumors using sickle cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imaging and targeting tumors using sickle cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3722630